SciTransfer
Organization

AMIRES SRO

Czech innovation SME specializing in pilot line scale-up and technology transfer across electronics, energy, and biomedical sectors.

Innovation consultancydigitalCZSME
H2020 projects
29
As coordinator
0
Total EC funding
€5.6M
Unique partners
294
What they do

Their core work

AMIRES is a Czech innovation and technology transfer consultancy that helps EU research consortia bridge the gap between laboratory results and industrial adoption. They specialize in pilot line scale-up, exploitation strategy, and business development across advanced manufacturing, electronics, and energy technologies. With 29 H2020 projects spanning at least seven different technical domains — always as a service-providing partner, never as coordinator — their value lies in cross-sector innovation management rather than deep single-domain R&D. They repeatedly appear in projects building open-access pilot lines and digital innovation hubs, suggesting they help consortia plan market entry and commercial exploitation.

Core expertise

What they specialise in

Pilot line scale-up and open access infrastructureprimary
8 projects

Central to PI-SCALE, InSCOPE, InPulse, MedPhab, PHABULOUS, MANUELA, OASIS, and SmartEEs — all focused on scaling technologies from lab to pilot production.

Flexible and printed electronicsprimary
7 projects

Consistent involvement from PI-SCALE (OLEDs, 2016) through SmartEEs2 (structural/wearable electronics, 2020) and FlexFunction2Sustain (nano-functionalized surfaces).

Solar and thermal energy systemssecondary
8 projects

Eight energy projects including WASCOP, MOSAIC, SOLWARIS (CSP water saving), ComBioTES (thermal storage), FRIENDSHIP (solar heat for industry), and CONDOR (solar fuels).

Photonics and micro-opticssecondary
4 projects

POSEIDON (nanophotonics), MedPhab (photonic medical devices), PHABULOUS (micro-optics manufacturing), and INSPIRE (InP photonic circuits).

Additive manufacturing and sensor integrationemerging
3 projects

MANUELA (metal AM pilot line), TINKER (sensor packages via AM), and NanoQI (thin-film quality imaging) show a growing AM capability.

Biomedical technology commercializationemerging
5 projects

ULTRAPLACAD (cancer diagnostics), ORGANTRANS (3D bioprinting), MARVEL (extracellular vesicles), PANCAIM (pancreatic cancer AI), and Tumor-LN-oC (organ-on-chip).

Evolution & trajectory

How they've shifted over time

Early focus
Flexible electronics pilot lines
Recent focus
Energy storage and biomedical tech

In 2015–2018, AMIRES focused heavily on flexible and printed electronics — OLEDs, smart patches, automotive displays, and organic electronics pilot lines (MEDILIGHT, PI-SCALE, InSCOPE). From 2019 onward, their portfolio diversified substantially into thermal energy storage, solar industrial heat, photonics, additive manufacturing, and biomedical applications including organ-on-chip and cancer diagnostics. This broadening suggests they matured from an electronics-focused innovation services firm into a general-purpose technology transfer partner capable of operating across multiple deep-tech domains.

AMIRES is diversifying into health technologies and advanced photonics while maintaining its energy and manufacturing base, positioning itself as a versatile scale-up partner for any deep-tech consortium.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European27 countries collaborated

AMIRES operates exclusively as a consortium partner — across 29 projects, they have never served as coordinator. They work in large, multi-partner consortia (294 unique partners across 27 countries), which indicates they are trusted by many different project leads to deliver specific services within big collaborative efforts. Their wide partner base with low repeat-partner density suggests they are sought after for their cross-domain expertise rather than locked into a single research cluster.

AMIRES has collaborated with 294 distinct partner organizations across 27 countries, giving them one of the broader networks among Czech SMEs in H2020. Their connections span Western European research hubs (likely Germany, France, Netherlands, Spain) as well as Central and Eastern Europe.

Why partner with them

What sets them apart

AMIRES occupies a rare niche: a technology transfer SME that can operate credibly across electronics, energy, manufacturing, and biomedical projects. Most innovation consultancies specialize in one or two sectors, but AMIRES has built a track record in seven H2020 pillars. For consortium builders, they offer a proven partner for exploitation planning and pilot line commercialization — someone who already knows how to navigate the path from TRL 4–5 research to industrial-scale validation, and who brings a 294-organization contact network to the table.

Notable projects

Highlights from their portfolio

  • PANCAIM
    Their highest-funded project (EUR 358,750) and a move into AI-driven personalized medicine for pancreatic cancer — a significant departure from their electronics roots.
  • ComBioTES
    Second-highest funding (EUR 250,985) in bio-based thermal energy storage, representing their deepest commitment to the energy transition space.
  • SmartEEs2
    EUR 351,312 for a Digital Innovation Hub in emerging electronics — reflects their core business of helping new technologies reach market adoption.
Cross-sector capabilities
Energy systems and thermal storageBiomedical devices and diagnosticsAdvanced manufacturing and additive processesEnvironmental and sustainability technologies
Analysis note: AMIRES's exact service offering (exploitation planning, market studies, business development, or technical pilot line operation) cannot be fully confirmed from project data alone — their consistent participant-only role across highly diverse technical domains strongly suggests an innovation services model, but the specific nature of their contribution within each consortium is inferred from patterns rather than stated explicitly.